TB-500 is a synthetic research peptide associated with the thymosin beta-4 pathway and is commonly discussed in laboratory research involving cell migration, actin-related processes and tissue-repair models. In Australia, however, it is important to separate laboratory research interest from claims about human treatment. The Therapeutic Goods Administration (TGA) lists TB-500 among examples of unapproved peptide products and states that unapproved peptides have not been evaluated by the TGA for safety, quality or effectiveness.
For Australian researchers looking for a clearly specified laboratory product, Meditech Plus Australia supplies TB500 – 10mg as a research-grade compound in lyophilised powder form. The product page states that each vial contains 10mg of TB-500 and is intended for laboratory research only, not human consumption.
What Is TB-500?
TB-500 is generally described in research and anti-doping literature as a synthetic peptide related to a fragment of thymosin beta-4. WADA-supported research identifies its active content as the N-terminal acetylated 17–23 fragment of thymosin beta-4, known as Ac-LKKTETQ. Research involving thymosin beta-4 and related fragments has examined actin binding, cellular movement and other biological processes, but experimental findings should not be presented as proven human benefits.
That distinction matters when reading online claims about “healing”, “recovery” or “mobility”. In Australia, TB-500 is not a TGA-approved therapeutic product, so research descriptions should not be interpreted as medical advice or evidence that the compound treats injuries or health conditions.

What Does Meditech Plus Australia Supply?
Meditech Plus Australia lists the following specifications for its TB-500 product:
- Compound: TB-500
- Quantity: 10mg per vial
- Form: lyophilised powder
- Grade: research-grade compound
- Supplier: Meditech Plus Australia
- Listed price at the time of research: $95
The website also states that its research products are third-party tested and batch certified and provides a dedicated Certificate of Analysis section for laboratory documentation. The TB-500 page additionally describes the product as batch verified and precision formulated.
For research teams, these details are more useful than exaggerated performance language. Clear vial strength, physical form, batch documentation and supplier traceability can help laboratories compare research materials more consistently.
Before ordering, researchers should also confirm that available batch documentation matches the vial supplied and fits their institution’s internal procurement and handling requirements.
Australian Shipping and Purchasing Considerations
Meditech Plus Australia advertises fast Australian shipping and free shipping on orders over $200. Its policy states that orders are dispatched through Australia Post and trusted courier services, with delivery timeframes treated as estimates rather than guarantees.
The refund policy also deserves attention. Because the products are treated as sensitive research materials, sales are generally final unless there is a verified issue. Damaged, incomplete, incorrectly supplied or manufacturing-fault orders should be reported within 48 hours of delivery.
Research-Only Status Is Essential
Meditech Plus Australia states that its products are for laboratory, analytical and research purposes only and are not intended for human consumption, therapeutic application, medical treatment or personal administration.
The TGA has recently increased its compliance focus on unapproved peptide products and warns that advertising unapproved therapeutic goods to Australian consumers is generally unlawful.
For qualified laboratories comparing TB-500 research peptide options in Australia, Meditech Plus Australia offers a 10mg lyophilised format, batch-certification claims, Australian dispatch and a listed price of $95. The strongest purchasing decision should be based on verified documentation, research suitability, lawful use and transparent supplier policies rather than unsupported therapeutic promises.
📅 Last updated: